New Genetic Risk Factors for Depression Identified for First Time Across All Major Global Populations
Depression is a highly prevalent disorder, and researchers still have a lot to learn about its biological underpinnings.
Related Articles
Proteins That Shape DNA Are Able to Shift Gears
A study reveals the structural maintenance of chromosomes proteins that shape our DNA can switch directions.
Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia
The placebo effect can relieve pain by activating the brain’s pain inhibition system via endogenous opioidergic signals.
3300-year-old baboon skull may tell of mysterious ancient kingdom
East African artifact may be first known treasure recovered from the “fantasy land” of Punt
JPM: Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy
Roche has exercised its option to license a novel capsid from Dyno Therapeutics for use in a gene therapy program for an undisclosed neurological disease.
AI-Designed Antivenom Counteracts Toxins from Snakebites in Mice
The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional antivenoms fail.
RANKL treatment restores thymic function and improves T cell–mediated immune responses in aged mice
RANK ligand administration reversed age-dependent thymic involution and rejuvenated T cell immunity in mice.
Nanoscopy Unravels the Interplay Between Antibodies and CD20 in Immunotherapy
Researchers have developed a new microscopic method to observe the interactions of therapeutic antibodies with target molecules on tumor cells.
The Shadow of Cognitive Laziness in the Brilliance of LLMs
LLMs can supercharge learning—but is it making us smarter or just lazier? It might be a bit of both.
Longevity Breakthrough: Scientists Restore “Youthful” Enzyme Activity To Combat Aging
Innovative therapies revive a once-undruggable mitochondrial aging regulator through a revolutionary enzyme activation mechanism. Researchers at CCM Biosciences, Inc. have leveraged a novel biophysical mechanism…
JPM: More “Smaller, Smarter” M&A Deals Expected in 2025, EY Predicts
EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived 51% during 2024, to 92 from 186…